Diet & Health
Revise Diet & Health for Biology 1 (IAL) WBI11 (AS Level) — revision notes and instant AI marking. Free to start.
Diet & Health: Risk Factors, Data & CVD
🧠 Big idea: Cardiovascular disease is driven by a tangle of lifestyle and biological risk factors — and the whole chapter is really about learning to read scientific evidence carefully: spotting genuine patterns, not confusing correlation with causation, and judging whether a study is actually trustworthy.
📋 Summary — What This Chapter Covers
- CVD risk factors: lifestyle (diet, blood pressure, smoking) vs uncontrollable factors (genetics, age, biological sex)
- Dietary antioxidants: the vitamin C/heart disease story — a classic example of conflicting evidence
- Core Practical 2: titrating vitamin C against DCPIP to build a calibration curve
- Interpreting data: describing data, drawing conclusions, and judging validity — without falling into the correlation-causation trap
- Designing good studies: sample size, randomisation, controls, repetition, avoiding bias
- Perceived vs actual risk: why people fear flying more than driving, statistically speaking
- Cholesterol & lipoproteins: HDL ("good") vs LDL ("bad") and why the ratio matters more than either alone
- Reducing CVD risk: diet, smoking cessation, exercise — and how public health messaging uses this evidence
- Treatments for CVD: antihypertensives, statins, anticoagulants, platelet inhibitors — their benefits and risks
1. CVD Risk Factors
Cardiovascular disease (CVD) is an umbrella term for anything going wrong with your heart and blood vessels. It's almost always linked to two underlying processes, and it's worth nailing the difference between them because exam questions love testing this:
Thrombosis — a blood clot forms in an artery, often triggered by a ruptured atheroma, which can block blood flow entirely.
Think of atherosclerosis as the slow build-up of gunk narrowing a pipe over years, and thrombosis as the sudden clog that finally blocks it. One sets the scene; the other delivers the crisis (heart attack or stroke).
What exactly is a "risk factor"?
A risk factor is anything statistically linked to a higher chance of developing a disease. Crucially — a risk factor is not a guarantee. A smoker isn't certain to get lung cancer; they just have a much higher probability than a non-smoker. This distinction (risk vs certainty) comes up constantly in exam answers.
Risk factors fall into four broad categories:
| Category | Example |
|---|---|
| Lifestyle | Diet, smoking, alcohol, exercise |
| Substances in body/environment | Air pollution, asbestos |
| Genetic predisposition | Inherited alleles affecting cholesterol handling |
| Other biological factors | Age, biological sex |
Many diseases arise from the interaction of several risk factors at once — e.g. someone who smokes, eats a high-cholesterol diet, AND doesn't exercise has a much higher combined risk than any single factor would suggest alone. This is why public health advice targets multiple behaviours at once rather than just one.
Lifestyle factors and their mechanisms
| Factor | How it increases CVD risk |
|---|---|
| Diet high in saturated fat | Raises blood cholesterol → more atheroma formation → more thrombosis risk |
| Diet high in salt | Raises blood pressure |
| High blood pressure | Damages artery walls → more atheroma formation |
| Smoking | 3 mechanisms (see below) — carbon monoxide, nicotine, and reduced antioxidants |
2. Nicotine increases platelet agglutination (stickiness) → higher thrombosis risk.
3. Smoking decreases antioxidant levels in the blood → more damage to the cells lining arteries → more atheroma formation.
Non-lifestyle (uncontrollable) factors
| Factor | Associated risk |
|---|---|
| Genetics | Inherited alleles can predispose someone to high blood pressure or high cholesterol |
| Age | Risk rises with age — blood vessels become more fragile and plaque accumulates over time |
| Biological sex | Men are roughly 3× more likely to suffer CVD than premenopausal women, likely due to lower oestrogen (a hormone linked to raising "good" cholesterol) |
Explain why having a diet high in saturated fat AND smoking together produces a greater risk of CVD than either factor alone would predict.
2. Dietary Antioxidants & CVD
This section is really a case study in how scientific understanding evolves — and how conflicting evidence should be handled.
Antioxidant vitamins include:
| Vitamin | Found in |
|---|---|
| Vitamin A | Orange vegetables (carrots, sweet potato) |
| Vitamin C | Citrus fruits |
| Vitamin E | Leafy vegetables, some nuts and oils |
The logic seemed clean: vitamin C helps build connective tissue, so more of it should mean healthier artery linings, less damage, and less atherosclerosis.
• 13.2% of men with low vitamin C had a heart attack
• 3.8% of men with normal vitamin C had a heart attack
This looked like strong support for "more vitamin C = less heart disease."
But then a 2016 meta-analysis (a study that pools and analyses the results of many existing studies) found no clear relationship between vitamin C intake and reduced heart disease risk — and even suggested antioxidant supplements could be harmful to circulatory health.
A single study found a strong correlation between low vitamin C and heart attacks. Explain why this alone is not enough to conclude that low vitamin C causes heart attacks.
3. Core Practical 2 — Vitamin C Content of Food & Drink
Vitamin C (chemical name: ascorbic acid) is a good reducing agent, meaning it's easily oxidised. This chemical property is exactly what the practical exploits.
Method (the exam-relevant steps)
- Make a series (e.g. 6) of known vitamin C concentrations by serial dilution.
- Measure 1 cm³ of DCPIP solution into a test tube.
- Add vitamin C solution drop by drop from a pipette/burette.
- Shake for a set time (this shaking time is a control variable).
- Record the volume (number of drops) needed to turn the DCPIP colourless.
- Repeat 3 times per concentration and average.
- Repeat for every known concentration.
- Plot a graph: volume of vitamin C needed to decolourise DCPIP (y-axis) vs concentration of vitamin C (x-axis).
Shape of the graph: as vitamin C concentration increases, the volume needed to decolourise DCPIP decreases — it's an inverse relationship (a downward curve/line).
Why is it important to keep the shaking time constant for every concentration tested in this experiment?
4. Interpreting Data on Risk Factors
This is arguably the most exam-heavy section of the whole chapter — questions here follow an extremely predictable three-part structure: describe → conclude → evaluate validity. Get comfortable with all three and you'll pick up marks reliably.
Step 1: Describing data
Just state what the data shows — using actual numbers, not vague words. "Risk increases with age" is weak. "Risk increases from 1.00 in the 20–39 age group to 2.4 in the 80+ age group" is strong.
Step 2: Drawing conclusions
Step 3: Evaluating validity
Ask yourself these questions about any study:
| Question | Why it matters |
|---|---|
| Is the sample size large? | Larger samples are more likely to represent the whole population |
| Is there a control group? | Isolates the effect of the variable being tested from other factors |
| Has it been repeated? | Repetition (by the same or other researchers) shows reliability |
| Were other variables controlled? | Otherwise you can't be sure what actually caused the effect |
| Is there bias? | E.g. funding from a company wanting a particular result |
| Is the difference statistically significant? | Rules out "it might just be random chance" |
Worked Example (from the specification)
A study of 523 non-smoking partners of smokers found: relative risk of CVD = 1.00 at 0 cigarettes/day exposure, 1.23 at 1–19 cigarettes/day, and 1.31 at ≥20 cigarettes/day.
Describe: Relative risk of CVD increases as exposure to secondhand smoke increases — from 1.00 with no exposure, to 1.23 at 1–19 cigarettes/day, to 1.31 at 20+ cigarettes/day.
Conclude: There is a correlation between increased secondhand smoke exposure and increased relative risk of CVD. (Avoid saying smoking "causes" this from one study alone.)
Validity: 523 people is a fairly small sample; this is only one study; there's no control for other risk factors (age, diet, exercise) that might differ between groups; and no statistical test is mentioned, so we can't confirm significance.
Recognising conflicting evidence
One study is never enough. Studies of similar design should be pooled in a meta-analysis. If different studies point in different directions, that's conflicting evidence — usually a sign that an unmeasured third variable is influencing the results. More research is then needed to figure out which pattern is actually correct.
A newspaper headline reads: "Study proves eating chocolate causes heart disease." Explain two reasons why this headline is scientifically problematic, based on how you should interpret data.
5. Designing Studies into the Effects of Risk Factors
If Section 4 is about judging a study, this section is about what makes a study good in the first place. Think of it as a checklist for the "perfect" experiment.
| Feature | Why it matters |
|---|---|
| Representative sample | Large and randomly selected — avoids bias from picking people with similar lifestyles (e.g. friends, gym members) |
| Control variables | The more variables controlled, the more reliable and valid the results |
| Avoiding bias | No manipulation of sampling or data to favour a particular outcome (watch for conflicts of interest, e.g. company-funded research) |
| Experimental control / placebo | A group identical in every way except the variable being tested is absent — isolates cause and effect |
| Repetition | Repeats within a study should give similar (reliable) results |
| Reproducibility | The entire study should be repeatable by other scientists — hence why methods are always published in full |
A researcher wants to test whether a new drug lowers blood pressure. They recruit volunteers only from people already attending a gym. Explain why this is a weak sampling method.
6. Perception of Risk vs Actual Risk
Risk = the statistical chance or probability of a harmful event occurring, backed by scientific evidence. But how risky something feels to a person often has very little to do with the actual numbers.
| Risk can be OVERESTIMATED because of... | Risk can be UNDERESTIMATED because of... |
|---|---|
| Misleading media coverage | Lack of information |
| Overexposure to information | Misunderstanding of the risk factors involved |
| Personal experience of the risk | Lack of personal experience |
| Unfamiliarity with the event | Unfamiliarity with the event (yes — cuts both ways!) |
| The event causing severe harm | Harm being non-immediate/delayed |
| Lack of enjoyment of the activity | Enjoyment of the activity |
Annual risk of dying in a plane crash: about 1 in 4.5–5.5 million.
Despite driving being thousands of times riskier, far more people fear flying than driving — largely because plane crashes are rare, dramatic, unfamiliar, and heavily covered by media, while car accidents are common and familiar (so they feel "normal" and safe).
Notice how this connects directly to smoking and diet: people often underestimate the risk of a poor diet because the harm is slow and delayed (non-immediate), while they might overestimate rarer, more dramatic causes of death.
Suggest why someone might underestimate the health risk posed by a diet high in saturated fat.
7. Cholesterol & Lipoproteins
Cholesterol itself is a type of lipid the body needs — for cell membranes, sex hormones, and bile. The problem isn't cholesterol existing; it's how it's transported and in what balance.
Since cholesterol doesn't dissolve in water (blood plasma is water-based), it has to be packaged into lipoproteins — spherical particles made of lipid + protein — to travel around the bloodstream.
| High Density Lipoproteins (HDL) | Low Density Lipoproteins (LDL) | |
|---|---|---|
| Contains | Unsaturated fat, cholesterol, protein | Saturated fat, cholesterol, protein |
| Direction of transport | Body tissues → liver (for recycling/excretion) | Liver → bloodstream → cells |
| Effect on blood cholesterol | Reduces it when too high | Increases it when too low |
| Nickname | "Good" cholesterol | "Bad" cholesterol |
| Extra role | Helps remove cholesterol from atheroma plaques | Excess LDL blocks cell receptors → cholesterol builds up in blood → contributes to plaque formation |
Evaluating lipoprotein/CVD data
Exactly the same checklist from Section 4 applies here: sample size, which individuals were sampled (can results be generalised?), presence of a control group, and statistical significance (check those error bars again!).
Worked Example
A study of 300 men (aged 40–80) tracked LDL/HDL levels against CVD event rate over 30 weeks. Result: LDL group ≈ 28% CVD event rate (with wide error bars overlapping the HDL group); HDL group ≈ 18% (error bars also overlapping).
Describe: CVD event rate is higher with LDL (≈28%) than with HDL (≈18%).
Conclude: Because the standard deviation bars overlap, there is no statistically significant difference between the two groups — despite the apparent difference in the bar heights!
Validity: 300 men is a small sample for a whole population; only men aged 40–80 were studied (can't generalise to women or younger/older people); other CVD risk factors (smoking, diet, exercise) weren't measured or controlled.
Correlation vs Causation — Cholesterol Edition
There IS good evidence linking high blood cholesterol to CVD: statins (which lower cholesterol) reduce CVD risk; diets high in saturated fat (which raise LDL) are linked to more CVD events; lowering total cholesterol is linked to fewer major coronary events.
But even with this much converging evidence, remember: a correlation between a high-saturated-fat diet and raised LDL cholesterol doesn't automatically prove causation on its own — there could be a third variable, such as genetic differences in how efficiently someone's body metabolises dietary fats.
Explain why LDL cholesterol is often called "bad" cholesterol, and why this label is a slight oversimplification.
8. Measures to Reduce CVD Risk
Diet
Diets high in saturated fat have been linked (though not conclusively, as covered above) to increased CVD risk. Food labelling — including traffic light labels (red = high, orange = medium, green = low for sugar, saturated fat, salt) — helps consumers make informed choices.
Measuring obesity
| Measure | How it's calculated | Healthy range |
|---|---|---|
| Waist-to-hip ratio | Waist circumference ÷ hip circumference | Women: <0.86 | Men: <0.9 |
| BMI | Mass (kg) ÷ height² (m²) | 18.5–24.9 = normal; 25–29.9 = overweight; 30+ = obese; <18.5 = underweight |
Smoking & Exercise
Public health responses to the CVD-smoking link include health warnings on packets, media portrayal of smoking as unhealthy, and free stop-smoking support materials/prescriptions. For exercise, initiatives include more PE hours in schools and targeted campaigns for specific groups (e.g. teenagers).
9. Treatments for CVD: Benefits & Risks
Prevention (reducing risk factors) is always the best strategy, but CVD is common enough that treatment is often necessary. There are four main drug categories to know — and for each, you should know how it works mechanistically, not just its name.
Antihypertensives (lower blood pressure)
- Beta blockers — prevent increases in heart rate
- Vasodilators (incl. ACE inhibitors) — increase blood vessel diameter; ACE inhibitors specifically block production of angiotensin (a hormone that constricts vessels), keeping arteries dilated
- Diuretics — reduce blood volume by decreasing sodium (and therefore water) reabsorption in the kidneys
Lower blood pressure → less arterial endothelial damage → less atheroma/thrombosis risk.
Statins (lower blood cholesterol)
Statins block a liver enzyme needed to make cholesterol. This lowers LDL concentration in the blood (reducing atheroma formation) and also reduces inflammation in the arterial lining.
Anticoagulants (reduce blood clotting)
E.g. warfarin, which decreases the level of prothrombin in the blood — reducing new clot formation and lowering thrombosis risk.
Platelet inhibitors (a type of anticoagulant)
E.g. aspirin and clopidogrel — prevent platelets clumping together, stopping clots from forming in the first place.
| Drug type | Key benefit | Key risk |
|---|---|---|
| Antihypertensives | Reduce blood pressure; effects can be monitored at home | Headaches, drowsiness, palpitations, swelling, persistent cough — side effects can cause patients to stop taking them |
| Statins | Lower "bad" LDL; raise "good" HDL | Slow to become effective; need long-term use; muscle/joint pain, liver damage; may cause false sense of security |
| Anticoagulants | Reduce new clot formation; shrink existing clots | Excessive bleeding risk (incl. internal); fainting, osteoporosis; can harm a foetus |
| Platelet inhibitors | Reduce new clot formation | Excessive bleeding; rashes, liver dysfunction, stomach lining damage; combining types raises risk |
Explain how ACE inhibitors reduce the risk of CVD, linking your answer to blood pressure and arterial damage.
🧷 What to Memorise
✅ Concepts Checklist
🎯 Exam Tips & Common Mistakes
• "Draw a conclusion from this data" (correlation, not causation)
• "Evaluate the validity of this study" (sample size, controls, bias, statistical significance)
• "Explain how [drug type] reduces the risk of CVD" (mechanism-based answer)
• "Suggest why perceived risk might differ from actual risk in this scenario"
• "Explain the roles of HDL and LDL in cholesterol transport"
- 2. Dietary Antioxidants & CVD
- 3. Core Practical 2 — Vitamin C Content of Food & Drink
- 7. Cholesterol & Lipoproteins
- 9. Treatments for CVD: Benefits & Risks
- 🎯 Exam Tips & Common Mistakes
- Smoking & Exercise
Read the full Diet & Health notes free
That's the preview — create a free account to read the rest, plus flashcards and practice questions with instant AI marking. No credit card.
Unlock the full notes free →